SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

American Renal Associates Holdings, Inc. – ‘10-K’ for 12/31/17 – ‘EX-31.2’

On:  Tuesday, 3/6/18, at 4:29pm ET   ·   For:  12/31/17   ·   Accession #:  1498068-18-12   ·   File #:  1-37751

Previous ‘10-K’:  ‘10-K’ on 3/8/17 for 12/31/16   ·   Next:  ‘10-K’ on 9/5/19 for 12/31/18   ·   Latest:  ‘10-K’ on 3/16/20 for 12/31/19

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/06/18  American Renal Assocs Holdin… Inc 10-K       12/31/17  109:11M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.63M 
 2: EX-10.11    Material Contract                                   HTML     43K 
 3: EX-21.1     Subsidiaries List                                   HTML     90K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     27K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     35K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     35K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     30K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     30K 
15: R1          Document and Entity Information                     HTML     55K 
16: R2          Consolidated Balance Sheets                         HTML    121K 
17: R3          Consolidated Balance Sheets (Parenthetical)         HTML     46K 
18: R4          Consolidated Statements of Operations               HTML     98K 
19: R5          Consolidated Statements of Comprehensive Income     HTML     42K 
20: R6          Consolidated Statements of Changes in Equity        HTML    126K 
21: R7          Consolidated Statements of Changes in Equity        HTML     31K 
                (Parenthetical)                                                  
22: R8          Consolidated Statements of Cash Flows               HTML    166K 
23: R9          Basis of Presentation and Organization              HTML     34K 
24: R10         Summary of Significant Accounting Policies          HTML     93K 
25: R11         Initial Public Offering                             HTML     50K 
26: R12         Cash                                                HTML     34K 
27: R13         Prepaid Expenses and Other Current Assets           HTML     36K 
28: R14         Acquisitions                                        HTML     45K 
29: R15         Fair Value Measurements                             HTML    102K 
30: R16         Property and Equipment                              HTML     44K 
31: R17         Intangible Assets and Goodwill                      HTML     57K 
32: R18         Accrued Expenses and Other Current Liabilities      HTML     43K 
33: R19         Variable Interest Entities                          HTML     36K 
34: R20         Noncontrolling Interests Subject to Put Provisions  HTML     59K 
35: R21         Changes in Ownership Interest in Consolidated       HTML     45K 
                Subsidiaries                                                     
36: R22         Debt                                                HTML     76K 
37: R23         Leases                                              HTML     53K 
38: R24         Income Taxes                                        HTML    101K 
39: R25         Earnings (Loss) Per Share                           HTML     69K 
40: R26         Equity                                              HTML     34K 
41: R27         Stock-Based Compensation                            HTML    113K 
42: R28         Related Party Transactions                          HTML     47K 
43: R29         Commitments and Contingencies                       HTML     36K 
44: R30         Certain Legal Matters                               HTML     47K 
45: R31         Employee Benefit Plan                               HTML     30K 
46: R32         Concentrations                                      HTML     32K 
47: R33         Selected Quarterly Financial Data (Unaudited)       HTML     76K 
48: R34         Subsequent Event                                    HTML     30K 
49: R35         Schedule Ii - Valuation and Qualifying Accounts     HTML     45K 
50: R36         Summary of Significant Accounting Policies          HTML    138K 
                (Policies)                                                       
51: R37         Summary of Significant Accounting Policies          HTML     31K 
                (Tables)                                                         
52: R38         Cash (Tables)                                       HTML     33K 
53: R39         Prepaid Expenses and Other Current Assets (Tables)  HTML     36K 
54: R40         Acquisitions (Tables)                               HTML     37K 
55: R41         Fair Value Measurements (Tables)                    HTML     98K 
56: R42         Property and Equipment (Tables)                     HTML     43K 
57: R43         Intangible Assets and Goodwill (Tables)             HTML     59K 
58: R44         Accrued Expenses and Other Current Liabilities      HTML     44K 
                (Tables)                                                         
59: R45         Noncontrolling Interests Subject to Put Provisions  HTML     53K 
                (Tables)                                                         
60: R46         Changes in Ownership Interest in Consolidated       HTML     46K 
                Subsidiaries (Tables)                                            
61: R47         Debt (Tables)                                       HTML     57K 
62: R48         Leases (Tables)                                     HTML     47K 
63: R49         Income Taxes (Tables)                               HTML     99K 
64: R50         Earnings (Loss) Per Share (Tables)                  HTML     67K 
65: R51         Stock-Based Compensation (Tables)                   HTML    100K 
66: R52         Selected Quarterly Financial Data (Unaudited)       HTML     75K 
                (Tables)                                                         
67: R53         Basis of Presentation and Organization (Details)    HTML     42K 
68: R54         Summary of Significant Accounting Policies          HTML     96K 
                (Details)                                                        
69: R55         Initial Public Offering (Details)                   HTML    124K 
70: R56         Cash (Details)                                      HTML     37K 
71: R57         Prepaid Expenses and Other Current Assets           HTML     34K 
                (Details)                                                        
72: R58         Acquisitions (Details)                              HTML     53K 
73: R59         Fair Value Measurements - Narrative (Details)       HTML     40K 
74: R60         Fair Value Measurements - Schedule of fair value    HTML     85K 
                (Details)                                                        
75: R61         Fair Value Measurements - Fair value rollforward    HTML     37K 
                of tax receivable agreement liability (Details)                  
76: R62         Property and Equipment (Details)                    HTML     50K 
77: R63         Intangible Assets and Goodwill - Schedule of        HTML     52K 
                intangible assets (Details)                                      
78: R64         Intangible Assets and Goodwill - Estimated annual   HTML     44K 
                amortization expense (Details)                                   
79: R65         Intangible Assets and Goodwill - Changes in the     HTML     38K 
                value of goodwilll (Details)                                     
80: R66         Accrued Expenses and Other Current Liabilities      HTML     45K 
                (Details)                                                        
81: R67         Variable Interest Entities (Details)                HTML     32K 
82: R68         Noncontrolling Interests Subject to Put Provisions  HTML     61K 
                (Details)                                                        
83: R69         Changes in Ownership Interest in Consolidated       HTML     45K 
                Subsidiaries (Details)                                           
84: R70         Debt - Schedule of long term-term debt (Details)    HTML     56K 
85: R71         Debt - Narrative (Detail)                           HTML    126K 
86: R72         Debt Debt - Scheduled maturities of long-term debt  HTML     47K 
                (Details)                                                        
87: R73         Leases (Details)                                    HTML     47K 
88: R74         Leases - Schedule of Future Minimum Lease Payments  HTML     82K 
                (Details)                                                        
89: R75         Income Taxes - Provision (Benefit) for Income       HTML     48K 
                Taxes (Details)                                                  
90: R76         Income Taxes - Significant components of deferred   HTML     67K 
                tax assets and liabilities (Details)                             
91: R77         Income Taxes Income Taxes - Narrative (Details)     HTML     37K 
92: R78         Income Taxes - Reconciliation of the federal        HTML     51K 
                statutory rate (Details)                                         
93: R79         Earnings (Loss) Per Share (Details)                 HTML     68K 
94: R80         Equity (Details)                                    HTML     50K 
95: R81         Stock-Based Compensation - Narrative (Details)      HTML     61K 
96: R82         Stock-Based Compensation - Equity Grants,           HTML     35K 
                Assumptions and Activity (Details)                               
97: R83         Stock-Based Compensation - Assumptions used for     HTML     50K 
                options granted (Details)                                        
98: R84         Stock-Based Compensation - Stock option activity    HTML     94K 
                (Details)                                                        
99: R85         Stock-Based Compensation - Restricted stock         HTML     62K 
                activity (Details)                                               
100: R86         Related Party Transactions (Details)                HTML     87K  
101: R87         Commitments and Contingencies (Details)             HTML     35K  
102: R88         Certain Legal Matters (Details)                     HTML     52K  
103: R89         Employee Benefit Plan (Details)                     HTML     29K  
104: R90         Concentrations (Details)                            HTML     28K  
105: R91         Selected Quarterly Financial Data (Unaudited)       HTML     51K  
                (Details)                                                        
106: R92         Schedule Ii - Valuation and Qualifying Accounts     HTML     37K  
                (Details)                                                        
108: XML         IDEA XML File -- Filing Summary                      XML    189K  
107: EXCEL       IDEA Workbook of Financial Reports                  XLSX    126K  
 9: EX-101.INS  XBRL Instance -- ara-20171231                        XML   2.46M 
11: EX-101.CAL  XBRL Calculations -- ara-20171231_cal                XML    342K 
12: EX-101.DEF  XBRL Definitions -- ara-20171231_def                 XML    725K 
13: EX-101.LAB  XBRL Labels -- ara-20171231_lab                      XML   2.22M 
14: EX-101.PRE  XBRL Presentations -- ara-20171231_pre               XML   1.28M 
10: EX-101.SCH  XBRL Schema -- ara-20171231                          XSD    218K 
109: ZIP         XBRL Zipped Folder -- 0001498068-18-000012-xbrl      Zip    306K  


‘EX-31.2’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


Exhibit 31.2
 
SECTION 302 CERTIFICATION 
 
I, Jonathan L. Wilcox, certify that:

1.
I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2017 of American Renal Associates Holdings, Inc. (the “registrant”);
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Chief Financial Officer
Date: March 6, 2018







Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/6/188-K
For Period end:12/31/17
 List all Filings 
Top
Filing Submission 0001498068-18-000012   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 10:48:40.1am ET